Beck F, Legleye S
Institut National de Prévention et d'Education pour la Santé (INPES), Paris, France.
Encephale. 2009 Dec;35 Suppl 6:S190-201. doi: 10.1016/S0013-7006(09)73470-0.
Epidemiological monitoring of drug use among adolescents or young adults is a major concern for public policy makers. This surveillance requires the use of adapted methodological solutions. This article presents how far epidemiological surveillance is a useful tool for monitoring drug use at adolescence. It also presents the results of the French general population surveys among adolescents or young adults, and the trends in the last decade. It relies on a survey among 17 years old adolescents and a general population survey among adults (analysis is restricted to people aged 18-25). A European school survey among 16 years old is also presented to compare the French situation to other European countries levels of use. The use of psychoactive substance increases fast with age during adolescence however results vary from one substance to another. Since year 2000, tobacco use is decreasing when alcohol use frequency appears stable between 2003 and 2005, although drunkenness has increased from 2000 to 2005. The frequency of lifetime or occasional use of cannabis appears stable since 2000. Among 17 years old, the proportion of regular users of cannabis has been stable between 2000 and 2005. Finally, the prevalence of ecstasy and cocaine increased during this period of time, despite being less than 4%, but the levels of the other illicit substances are low and stable. The results on alcohol variables and tobacco use in France are rather close to the European average. Four out of five 16 years old students had drunk alcohol during the past 12 months and 36 percent had been drunk during this period (vs 39% in the average European country). About one-third of the students had smoked cigarettes during the past 30 days (close to the 29% in the average European country). The use of cannabis, however, is clearly more prevalent in France. Almost one-third (31%) of the students had already used cannabis (vs 19% in the average European country). The use of inhalants was reported by 12 percent, which is close to the average, while 15 percent of the students had used tranquillisers or sedatives without a doctor's prescription, which is more than twice the European average (6%).
青少年或青年人群药物使用的流行病学监测是公共政策制定者主要关注的问题。这种监测需要采用合适的方法学解决方案。本文阐述了流行病学监测在多大程度上是监测青少年药物使用的有用工具。文章还呈现了法国针对青少年或青年人群的一般人群调查结果以及过去十年的趋势。它基于一项针对17岁青少年的调查以及一项针对成年人的一般人群调查(分析限于18至25岁人群)。还呈现了一项针对16岁青少年的欧洲学校调查,以将法国的情况与其他欧洲国家的使用水平进行比较。在青少年时期,精神活性物质的使用随年龄快速增加,不过不同物质的结果有所不同。自2000年以来,烟草使用呈下降趋势,而酒精使用频率在2003年至2005年期间看似稳定,尽管从2000年到2005年醉酒情况有所增加。自2000年以来,大麻终身使用或偶尔使用的频率看似稳定。在17岁人群中,大麻经常使用者的比例在2000年至2005年期间保持稳定。最后,在此期间摇头丸和可卡因的流行率有所上升,尽管低于4%,但其他非法物质的水平较低且稳定。法国关于酒精变量和烟草使用的结果与欧洲平均水平相当接近。五分之四的16岁学生在过去12个月内饮酒,其中36%在此期间喝醉过(欧洲平均国家为39%)。约三分之一的学生在过去30天内吸烟(接近欧洲平均国家的29%)。然而,大麻的使用在法国明显更为普遍。近三分之一(31%)的学生已经使用过大麻(欧洲平均国家为19%)。12%的学生报告使用过吸入剂,这接近平均水平,而15%的学生在没有医生处方的情况下使用过镇静剂或安眠药,这是欧洲平均水平(6%)的两倍多。